Teladoc Health, Inc. (TDOC) is a publicly traded Healthcare sector company. As of May 21, 2026, TDOC trades at $6.46 with a market cap of $1.15B and a P/E ratio of -5.64. TDOC moved -2.19% today. Year to date, TDOC is -10.99%; over the trailing twelve months it is -11.72%. Its 52-week range spans $4.40 to $15.21. Analyst consensus is buy with an average price target of $7.22. Rallies surfaces TDOC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
TDOC financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. TDOC recently traded at $6.46. Market cap is $1.15B. P/E ratio is -5.64. Revenue is $2.53B.
| Metric | Value |
|---|---|
| Price | $6.46 |
| Market Cap | $1.15B |
| P/E Ratio | -5.64 |
| EPS | $-1.14 |
| Dividend Yield | 0.00% |
| 52-Week High | $15.21 |
| 52-Week Low | $4.40 |
| Volume | 919 |
| Avg Volume | 0 |
| Revenue (TTM) | $2.53B |
| Net Income | $-200.32M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $2.53B | $-200.32M | $-1.14 |
| 2023 | $2.60B | $-220.37M | $-1.34 |
| 2022 | $2.41B | $-13.66B | $-84.60 |
| 2021 | $2.03B | $-428.79M | $-2.73 |
22 analysts cover TDOC: 0 strong buy, 7 buy, 15 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $7.22.